Hualan Biological Vaccine Inc. (SHE:301207)
China
· Delayed Price · Currency is CNY 19.25
-0.01 (-0.05%)
Apr 29, 2026, 3:04 PM CST
Hualan Biological Vaccine Market Cap
Hualan Biological Vaccine has a market cap or net worth of 11.46 billion as of April 28, 2026. Its market cap has increased by 13.96% in one year.
Market Cap
11.46B
Enterprise Value
8.90B
Revenue
1.20B
Ranking
n/a
PE Ratio
61.12
Stock Price
19.25
Market Cap Chart
Since February 18, 2022, Hualan Biological Vaccine's market cap has decreased from 28.12B to 11.46B, a decrease of -59.25%. That is a compound annual growth rate of -19.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 11.46B | 3.38% |
| Dec 31, 2025 | 11.08B | 6.40% |
| Dec 31, 2024 | 10.42B | -37.54% |
| Dec 29, 2023 | 16.68B | -6.46% |
| Dec 30, 2022 | 17.83B | -36.59% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chongqing Genrix Biopharmaceutical | 11.51B |
| Pacific Shuanglin Bio-pharmacy | 11.67B |
| Chengdu Olymvax Biopharmaceuticals | 11.68B |
| Vcanbio Cell & Gene Engineering Corp., | 11.92B |
| Chengdu Easton Biopharmaceuticals | 11.16B |
| Jiangxi Fushine Pharmaceutical | 10.63B |
| HitGen | 10.52B |
| InventisBio | 12.83B |